Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 166.00
+1.34 (0.81%)
Feb 18, 2026, 1:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 218.64 billion as of February 17, 2026. Its market cap has decreased by -31.08% in one year.
Market Cap
218.64B
Enterprise Value
259.71B
Revenue
88.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
166.00
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 218.64B, a decrease of -3.57%. That is a compound annual growth rate of -1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 218.64B | -4.38% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 547.09B |
| Ipca Laboratories | 378.43B |
| Ajanta Pharma | 369.39B |
| Gland Pharma | 302.54B |
| Emcure Pharmaceuticals | 278.80B |
| Wockhardt | 226.87B |
| Eris Lifesciences | 184.82B |
| NATCO Pharma | 158.46B |